Title: TACTI-004: a double-blinded, randomized phase 3 trial in patients with advanced/metastatic non-small cell cancer ...

Biohacking combines science and lifestyle changes, offering strategies like intermittent fasting and sleep optimization to ...

Our cells harbor a DNA detector termed cGAS to inform the immune system of viral and bacterial infections, cell death, as ...

Migraine, a common neurological condition, poses significant personal, social, and economic burdens, requiring proper ...

Since the dawn of civilization, humans have traded wildlife and wildlife products, such as ivory, shells, fur and feathers.

Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...

Researchers are studying how exercise influences breast cancer progression. Their findings show that physical activity can ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

New research reveals why women experience chronic pain more frequently than men, uncovering key biological differences in pain processing.

Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor (“TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...

PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell ...

A Review of the Research Progress and Application of Skin Care Ointments in Chronic Eczema Treatment ...